C.L.I.M.B. HIGHER CONTINUUM OF LEARNING TO IMPROVE MANAGEMENT WITH BOTULINUM TOXIN

View On IPO.GOV.AU

Registered: Registered/protected

Last updated on 1 Feb 2022

Owner Info

Ipsen Biopharm Limited

Ash Road, Wrexham Industrial Estate, Wrexham

LL13 9UF UNITED KINGDOM,

Serial Number

2188072 filed on 21 Jun 2021

Correspondent

Spruson & Ferguson

GPO Box 3898,

Sydney, NSW, 2001 AUSTRALIA,

C.L.I.M.B. HIGHER CONTINUUM OF LEARNING TO IMPROVE MANAGEMENT WITH BOTULINUM TOXIN

Classification Information

2188072

21 Jun 2021

21 Jun 2031

FIGURATIVE

Status Date	Action Taken
1^st Feb 2022	IP Right Registered correspondence sent
1^st Feb 2022	IP Right Registration Published
1^st Feb 2022	Status change to Registered/Protected
22^nd Nov 2021	Application Accepted correspondence sent
22^nd Nov 2021	IP Right has been Examined
22^nd Nov 2021	IP Right Acceptance Published
8^th Sept 2021	Early Acceptance Notice correspondence sent
8^th Sept 2021	Status change to Accepted
30^th Jun 2021	Awaiting examination
30^th Jun 2021	Word and image indexing completed